Titan Biotech Ltd.
| BSE: 524717 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE150C01011 |
| BSE 00:00 | 30 Oct | 127.05 |
-5.95 (-4.47%) |
OPEN
130.60 |
HIGH
133.00 |
LOW
126.35 |
| NSE 05:30 | 01 Jan | Titan Biotech Ltd |
| OPEN | 130.60 |
| PREVIOUS CLOSE | 133.00 |
| VOLUME | 66346 |
| 52-Week high | 194.15 |
| 52-Week low | 27.25 |
| P/E | 4.70 |
| Mkt Cap.(Rs cr) | 105 |
| Buy Price | 127.05 |
| Buy Qty | 95.00 |
| Sell Price | 127.05 |
| Sell Qty | 110.00 |
Titan Biotech Ltd. (TITANBIOTECH) - Market Capital
Market Cap
| COMPANY | LATEST(Rs) | CHG(%) | 52 Wk High | 52 Wk Low | MKT-CAP (RS CR) |
| Sun Pharma.Inds. | 465.75 | 1.97 | 564.90 | 315.20 | 111747.39 |
| Divi's Lab. | 3140.35 | 1.04 | 3388.00 | 1627.15 | 83360.59 |
| Dr Reddy's Labs | 4887.95 | -1.10 | 5514.65 | 2497.60 | 81276.83 |
| Cipla | 754.10 | -1.02 | 829.00 | 356.75 | 60806.86 |
| Biocon | 403.60 | -0.07 | 477.90 | 235.80 | 48432.00 |
| Aurobindo Pharma | 772.75 | 0.52 | 967.60 | 281.15 | 45275.42 |
| Torrent Pharma. | 2564.70 | 1.79 | 3040.00 | 1619.00 | 43399.85 |
| Cadila Health. | 417.70 | 1.58 | 447.95 | 212.70 | 42759.95 |
| Lupin | 908.40 | -1.68 | 1121.85 | 505.00 | 41177.77 |
| Abbott India | 15302.05 | 0.92 | 18569.00 | 11369.30 | 32516.86 |
| Alkem Lab | 2634.25 | -1.43 | 3089.55 | 1945.00 | 31492.46 |
| Apollo Hospitals | 2119.25 | 1.53 | 2331.95 | 1047.45 | 29483.00 |
| Ipca Labs. | 2313.10 | -1.56 | 2455.55 | 966.20 | 29341.67 |
| Piramal Enterp. | 1261.55 | 3.81 | 1829.47 | 608.00 | 28454.26 |
| Glaxosmi. Pharma | 1465.65 | -1.08 | 1805.00 | 1046.40 | 24829.58 |
| Pfizer | 4985.00 | -0.93 | 5273.55 | 3588.15 | 22806.38 |
| Syngene Intl. | 535.05 | -0.50 | 596.85 | 201.65 | 21402.00 |
| Dr Lal Pathlabs | 2294.95 | -0.80 | 2395.00 | 1181.80 | 19126.11 |
| Alembic Pharma | 963.45 | -0.65 | 1128.00 | 436.10 | 18936.61 |
| Sanofi India | 8003.75 | -0.20 | 8999.00 | 5900.05 | 18432.64 |
Quick Links for Titan Biotech:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
